burden of chronic diseases giovanni viegi, md. director of research, italian national research...
DESCRIPTION
Horton, The Lancet 2005TRANSCRIPT
Burden of chronic diseases
Giovanni Viegi, MD. Director of Research, Italian National Research Council
. Head, Pulmonary Environmental Epidemiology Unit,CNR Institute of Clinical Physiology, Pisa
.Professor of “Health Effects of Pollution”, School of Environmental Sciences, University of Pisa - Italy
. 2005-06 President, European Respiratory Society (ERS)
GARD Launch in Latin America
August 17, 11:15-11:30
The Lancet 2005;366:1514
Horton, The Lancet 2005
Horton, The Lancet 2005
Horton, The Lancet 2005
Strong et al, Lancet 2005
Strong et al, Lancet 2005
Strong et al, Lancet 2005
Strong et al, Lancet 2005
Presidents of respiratory societies participating in FIRS
Minino, NVSS 2006
2° edition:in preparation
EUROPEAN LUNG WHITE BOOK, 2003
EUROPEAN LUNG WHITE BOOK, 2003
Chapman et al, ERJ 2006
Lopez et al, ERJ 2006
Lopez et al, ERJ 2006 Part III of IV MALES
Lopez et al, ERJ 2006 Part IV of IV FEMALES
Mannino et al, ERJ 2006
Part I of II
Zielinski et al, ER
J 2006
(Viegi’s part)
MALES
Part II of II
Zielinski et al, ER
J 2006
(Viegi’s part)
FEMALES
Why is the Burden of COPD Increasing?
• In 2002: 1 in 10 is 60 yrs (629M)
• By 2020: 1 in 5 will be 60 yrs (2B)
• By 2150: 1in 3.3 will be 60 yrs
Why is the Burden of COPD Increasing?
The WHO estimates 1.1 billion smokers worldwide, increasing to 1.6 billion by 2025.
In low- and middle-income countries, smoking rates are increasing at an alarming rate.
Eur Respir J. 2006 Apr 12; [Epub ahead of print]
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM
Halbert, Eur Respir J 2006
Adults over 40 yr
Menezes, Lancet 2005
Respir Med. 2003 Feb;97(2):115-22. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies.In 1996, 5892 of the Obstructive Lung Disease in Northern Sweden (OLIN) Study's first cohort could be traced to a third follow-up survey, and 5189 completed responses (88%) were received corresponding to 79% of the original cohort from December 1985. Of the responders, a random sample of 1500 subjects were invited to a structured interview and a lung function test, and 1237 of the invited completed a lung function test with acceptable quality. In ages >45 years, the prevalence of COPD according to the BTS guidelines was 8%, while it was 14% according to the GOLD criteria and approximately a half of elderly smokers fulfilled the criteria for COPD according to both the BTS and the GOLD criteria. Of those fulfilling the BTS criteria for COPD, 94% were symptomatics, 69% had chronic productive cough, but only 31% had prior to the study been diagnosed as having either chronic bronchitis, emphysema, or COPD. The corresponding figures for COPD according GOLD were 88, 51, and 18%.
Masoli et al, Allergy 2004
Masoli et al, Allergy 2004
Masoli et al, Allergy 2004
GARD
WG-1: Epidemiology and Surveillance (G Viegi): Chair: G. Viegi, Italy (ERS); Co-Chairs: S. Buist, USA (GOLD), Y. Fukuchi (APSR).WHO-Liaison Officers: E. Mantsouranis.
Proposed initial composition: I. Annesi (ERS), R. Beasley (?), P. Burney (GA2LEN), W. Canonica (WAO), B. Chipps (ACAAI), E. Duran (ERS), J. Jardim (ALAT), D.S. Kim (APSR), A. Kocabas (TTS), C. Lai (AAAF), Lee Todd (BOLD), B. Lundback (ERS), J. Mallol (?), D. Mannino (ATS?), D. Nugmanova (WONCA), J.A. Odhiambo (IUATLD?), R Pawankar (ARIA?), J Vestbo (ERS).
General Objective
The goal of this WG is to develop a standardized process to obtain data risk factors, disease burden, trends, quality and affordability of care and the economic burden of chronic respiratory diseases (CRD) and allergies that can then be compared across countries.
Aims:
1. Use WHO programmes and non-WHO programmes to make an inventory of existing studies/reports that have collected data on prevalence, risk factors, severity, and economic burden of chronic respiratory diseases.
2. Collect these data at a country-based level.
3. Expand WHO internal initiatives (routine statistics, information systems, projection models) to cover respiratory and allergic diseases.